Showing 1 - 8 results of 8 for search 'I. V. Buravtsova', query time: 0.03s Refine Results
  1. 1
    Clinical efficacy of dacogen in myelodysplastic syndrome

    Clinical efficacy of dacogen in myelodysplastic syndrome by A. K. Golenkov, G. A. Dudina, I. V. Buravtsova, E. V. Kataeva, N. V. Oparina

    Published 2022-11-01
    Get full text
    Article
  2. 2
    Gene expression of vascular endothelial growth factors and their receptors in different variants of the course of multiple myeloma

    Gene expression of vascular endothelial growth factors and their receptors in different variants of the course of multiple myeloma by A K Golenkov, I V Buravtsova, G A Dudina, T D Lutskaia, T A Mitina, E V Kataeva, A F Karamysheva, E S Kakpakova, Iu A Sablina, A A Stavrovskaia

    Published 2013-07-01
    Get full text
    Article
  3. 3
    The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma

    The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma by T. D. Lutskaya, A. K. Golenkov, T. A. Mitina, I. V. Buravtsova, G. A. Dudina, L. L. Vysotskaya, E. V. Trifonova, E. V. Kataeva, O. V. Moskalets, V. V. Yazdovskiy

    Published 2014-07-01
    Get full text
    Article
  4. 4
    The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma

    The efficacy of therapy with rituximab (R-CHOP) in patients with diffuse large cells lymphoma by T. D. Lutskaya, A. K. Golenkov, T. A. Mitina, I. V. Buravtsova, G. A. Dudina, L. L. Vysotskaya, E. V. Trifonova, E. V. Kataeva, O. V. Moskalets, V. V. Yazdovskiy

    Published 2014-07-01
    Get full text
    Article
  5. 5
    Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine

    Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine by E. V. Kataeva, A. K. Golenkov, E. V. Trifonova, G. A. Dudina, T. A. Mitina, L. L. Vysotskaya, T. D. Lutskaya, I. V. Buravtsova, R. V. Gorenkov, Yu. Yu. Chuksina, V. V. Yazdovskiy

    Published 2014-07-01
    Get full text
    Article
  6. 6
    Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice

    Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice by A. K. Golenkov, L. L. Vysotskaya, E. V. Trifonova, T. A. Mitina, T. D. Lutskaya, E. V. Kataeva, G. A. Dudina, Yu. B. Chernykh, I. V. Buravtsova, A. N. Gurov, R. V. Gorenkov

    Published 2014-07-01
    Get full text
    Article
  7. 7
    Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice

    Treatment efficacy of chronic myeloid leukemia with imatinib in clinical practice by A. K. Golenkov, L. L. Vysotskaya, E. V. Trifonova, T. A. Mitina, T. D. Lutskaya, E. V. Kataeva, G. A. Dudina, Yu. B. Chernykh, I. V. Buravtsova, A. N. Gurov, R. V. Gorenkov

    Published 2014-07-01
    Get full text
    Article
  8. 8
    Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine

    Treatment of patients with refractory chronic lymphocytic leukemia with alemtuzumab, alone or in combination with fludarabine by E. V. Kataeva, A. K. Golenkov, E. V. Trifonova, G. A. Dudina, T. A. Mitina, L. L. Vysotskaya, T. D. Lutskaya, I. V. Buravtsova, R. V. Gorenkov, Yu. Yu. Chuksina, V. V. Yazdovskiy

    Published 2014-07-01
    Get full text
    Article

Search Tools: